Watch for Tirzepatide, a New Injectable Diabetes Med
There’s buzz about tirzepatide (Mounjaro), a new Rx injectable for type 2 diabetes.
You’ll hear that it’s the first “twincretin.”
That’s because this GLP-1/GIP agonist works in two ways to mimic incretins...hormones that help increase insulin release, decrease blood sugar, and promote fullness, especially after meals.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote